Daniel Dupret
President at AzurRx BioPharma SAS
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Charles Casamento | M | 78 | 7 years | |
| Ed Borkowski | M | 64 | 9 years | |
| Alastair Riddell | M | 74 | 9 years | |
| Yves Leblond | M | - |
AzurRx BioPharma SAS
 AzurRx BioPharma SAS Miscellaneous Commercial ServicesCommercial Services Part of First Wave Biopharma, Inc., AzurRx BioPharma SAS is a French company that provides bioscience and biotechnology research and development services. The company is based in Langlade, France. AzurRx BioPharma was acquired by First Wave Biopharma, Inc. from Protea Biosciences Group, Inc. on June 13, 2014 for $2.20 million. | 15 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jean-Marie Sonet | M | - |
Appligene Oncor SA
 Appligene Oncor SA Pharmaceuticals: OtherHealth Technology Part of Valiant Co., Ltd., Appligene Oncor SA is a French company that specializes in medicinal chemicals and botanical products. The company is based in Illkirch Graffenstaden, France. The company was founded by Daniel Dupret. Appligene Oncor was acquired by Quantum Biotechnologies, Inc. on February 17, 1999 for $1.24 million.
Protéus SA
 Protéus SA BiotechnologyHealth Technology Protéus SA discovers, engineers, and manufactures proteins for industrial applications. It operates as a biotechnology company that focuses on the discovery, engineering and manufacturing of proteins of industrial interest, and on the development of protein-based bioprocesses. The company was founded on August 11, 1998 and is headquartered in Paris, France. | - |
| Maged Shenouda | M | 59 | 4 years | |
| Jean-François Bloch | M | - |
Protéus SA
Protéus SA BiotechnologyHealth Technology Protéus SA discovers, engineers, and manufactures proteins for industrial applications. It operates as a biotechnology company that focuses on the discovery, engineering and manufacturing of proteins of industrial interest, and on the development of protein-based bioprocesses. The company was founded on August 11, 1998 and is headquartered in Paris, France. | - |
| Marc Vander Linden | M | - |
Protéus SA
Protéus SA BiotechnologyHealth Technology Protéus SA discovers, engineers, and manufactures proteins for industrial applications. It operates as a biotechnology company that focuses on the discovery, engineering and manufacturing of proteins of industrial interest, and on the development of protein-based bioprocesses. The company was founded on August 11, 1998 and is headquartered in Paris, France. | - |
| Vern Schramm | M | 82 | 4 years | |
| James Pennington | M | 81 | 4 years | |
| Emmanuel Maille | M | - |
Protéus SA
Protéus SA BiotechnologyHealth Technology Protéus SA discovers, engineers, and manufactures proteins for industrial applications. It operates as a biotechnology company that focuses on the discovery, engineering and manufacturing of proteins of industrial interest, and on the development of protein-based bioprocesses. The company was founded on August 11, 1998 and is headquartered in Paris, France. | - |
| Philippe Jais | M | - | 5 years | |
| Monica Gangal | F | - | 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 8 | 61.54% |
| France | 5 | 38.46% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Daniel Dupret
- Personal Network
